Explore every episode of the podcast JACC Podcast
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Serial Shock Severity Assessment: Some Answers. Still Many Questions. | ESC 2024 | 31 Aug 2024 | 00:11:36 | |
Rasha K. Al-Lamee, MD, PhD, JACC Deputy Editor and Navin K. Kapur MD discuss the work from the Cardiogenic Shock Working Group, which is an academic research consortium comprising ~40 hospitals in the U.S. and internationally. | |||
| Insights from RESHAPE-HF2 Trial | ESC 2024 | 31 Aug 2024 | 00:13:30 | |
Aakriti Gupta, MD, FACC, JACC Executive Associate Editor, and Stefan D. Anker, MD, discuss the insights from the RESHAPE-HF2 trial - an eight-year study on the efficacy of transcatheter edge-to-edge repair for mitral valve regurgitation in patients with heart failure. | |||
| Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM | 26 Aug 2024 | 00:11:19 | |
In the September 3, 2024, JACC issue, a major study evaluates the cardiovascular outcomes of second-line antihyperglycemic agents in type 2 diabetes, comparing SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas. The research reveals that SGLT2 inhibitors and GLP-1 receptor agonists offer superior cardiovascular protection over the other agents, highlighting their importance for patients with cardiovascular conditions. | |||
| JACC - May 28, 2024 Issue Summary | 20 May 2024 | 00:25:46 | |
Audio Summary of the May 28 issue of JACC, by Dr. Valentin Fuster | |||
| Safety and Efficacy of Metabolic Modulation with Ninerafaxstat in Nonobstructive Hypertrophic Cardiomyopathy: Phase 2 Study | 20 May 2024 | 00:13:02 | |
Commentary by Dr. Valentin Fuster | |||
| Clinical Outcome of Different Microvascular Injury Patterns after STEMI - A Multicenter Cardiac MRI Study | 20 May 2024 | 00:13:41 | |
Commentary by Dr. Valentin Fuster | |||
| Prognostic Value of MRR After Primary PCI: a Pooled Analysis of Individual Patient Data | 20 May 2024 | 00:10:49 | |
Commentary by Dr. Valentin Fuster | |||
| A Technology-Assisted Web Application for Consumer Access to a Non-prescription Statin Medication | 20 May 2024 | 00:08:18 | |
Commentary by Dr. Valentin Fuster | |||
| Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review | 20 May 2024 | 00:21:51 | |
Commentary by Dr. Valentin Fuster | |||
| Clinical Risk Assessment Across the Lifespan in Patients with Congenital Heart Disease: JACC Scientific Statement | 20 May 2024 | 00:06:42 | |
Commentary by Dr. Valentin Fuster | |||
| JACC - May 21, 2024 Issue Summary | 13 May 2024 | 00:22:36 | |
Audio Summary of the May 21 issue of JACC, by Dr. Valentin Fuster | |||
| An Inclisiran First Strategy vs Usual Care in Patients with Atherosclerotic Cardiovascular Disease | 13 May 2024 | 00:11:30 | |
Commentary by Dr. Valentin Fuster | |||
| Small Left Ventricle is Associated with an Increased Cardiovascular Risk in Patients with Atrial Fibrillation | 13 May 2024 | 00:11:55 | |
Commentary by Dr. Valentin Fuster | |||
| Continuous Rhythm Monitoring with Implanted Loop Recorders in Children and Adolescents with Brugada Syndrome | 26 Aug 2024 | 00:10:42 | |
In the September 3, 2024, issue of JACC, Dr. Valentin Fuster introduces a pivotal study on Brugada syndrome in children and adolescents. This research, led by Dr. Marco Berganti and colleagues, demonstrates how continuous monitoring with implanted loop recorders provides critical insights into arrhythmias and syncope in young patients, highlighting the potential for future AI-driven personalized care in this complex condition. | |||
| Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial | 13 May 2024 | 00:07:28 | |
Commentary by Dr. Valentin Fuster | |||
| Case Volumes and Outcomes among Early Career Interventional Cardiologists in the United States | 13 May 2024 | 00:08:49 | |
Commentary by Dr. Valentin Fuster | |||
| Managing Implanted Cardiac Electronic Devices in Patients with Severe Tricuspid Regurgitation: JACC State-of-the-Art Review | 13 May 2024 | 00:12:30 | |
Commentary by Dr. Valentin Fuster | |||
| Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week | 13 May 2024 | 00:20:01 | |
Commentary by Dr. Valentin Fuster | |||
| JACC - May 14, 2024 Issue Summary | 06 May 2024 | 00:24:39 | |
Audio Summary of the May 14 issue of JACC, by Dr. Valentin Fuster | |||
| Prevalence of Cardiovascular Disease and Risk Factors among National Football League Alumni and Family Members | 06 May 2024 | 00:09:44 | |
Commentary by Dr. Valentin Fuster | |||
| Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Cardiomyopathies | 06 May 2024 | 00:13:40 | |
Commentary by Dr. Valentin Fuster | |||
| Uniform or Sex-Specific Cardiac Troponin Thresholds to Rule Out Myocardial Infarction at Presentation | 06 May 2024 | 00:08:19 | |
Commentary by Dr. Valentin Fuster | |||
| Long-term Cardiovascular Risk Associated with Treatment of Attention-Deficit/Hyperactivity Disorder in Adults | 06 May 2024 | 00:08:05 | |
Commentary by Dr. Valentin Fuster | |||
| Ventricular Septal Rupture After Myocardial Infarction: JACC Focus Seminar 3/5 | 06 May 2024 | 00:09:34 | |
Commentary by Dr. Valentin Fuster | |||
| Antithrombotic Strategies for Patients with Peripheral Artery Disease: JACC Scientific Statement | 26 Aug 2024 | 00:22:45 | |
In the September 3rd, 2024 issue of JACC, a new scientific statement delves into antithrombotic strategies for peripheral artery disease (PAD), highlighting the challenges and advancements in treatment. The review emphasizes that while traditional therapies like aspirin and clopidogrel remain crucial, combining aspirin with low-dose rivaroxaban offers a promising approach for reducing major adverse events and limb outcomes, despite an increased bleeding risk. | |||
| JACC - May 7, 2024 Issue Summary | 29 Apr 2024 | 00:25:05 | |
Audio Summary of the May 7 issue of JACC, by Dr. Valentin Fuster | |||
| Combined effects of clonal hematopoiesis and degree of carotid stenosis on cardiovascular mortality | 29 Apr 2024 | 00:09:53 | |
Commentary by Dr. Valentin Fuster | |||
| Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction | 29 Apr 2024 | 00:11:22 | |
Commentary by Dr. Valentin Fuster | |||
| Association of Lipoprotein(a) Levels with Myocardial Infarction in Patients with Low Attenuation Plaque | 29 Apr 2024 | 00:13:47 | |
Commentary by Dr. Valentin Fuster | |||
| Mandibular Advancement vs CPAP for Blood Pressure Reduction in Patients with Obstructive Sleep Apnea | 29 Apr 2024 | 00:08:39 | |
Commentary by Dr. Valentin Fuster | |||
| JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction | 29 Apr 2024 | 00:09:01 | |
Commentary by Dr. Valentin Fuster | |||
| JACC - April 30, 2024 Issue Summary | 22 Apr 2024 | 00:22:21 | |
Audio Summary of the April 30 issue of JACC, by Dr. Valentin Fuster | |||
| Limb Outcomes with Ticagrelor Plus Aspirin in Patients with Diabetes Mellitus and Atherosclerosis | 22 Apr 2024 | 00:09:10 | |
Commentary by Dr. Valentin Fuster | |||
| Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives | 22 Apr 2024 | 00:09:21 | |
Commentary by Dr. Valentin Fuster | |||
| Permanent Pacemaker Implantation and Long-term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve Surgery | 22 Apr 2024 | 00:09:38 | |
Commentary by Dr. Valentin Fuster | |||
| JACC - August 27, 2024 Issue Summary | 19 Aug 2024 | 00:23:12 | |
In this episode, Dr. Valentin Fuster covers four original papers focusing on cardiovascular disease. Highlights include the effectiveness of semaglutide in reducing weight and improving heart failure symptoms, long-lasting effects of OPASAN on lipoprotein(a) levels, the impact of low-dose rivaroxaban plus aspirin on fragile patients post-revascularization, and the promising use of AI-based ECG for predicting biventricular dysfunction in congenital heart disease. | |||
| Association of Disrupted Delta Wave Activity During Sleep with Long-Term Cardiovascular Disease and Mortality | 22 Apr 2024 | 00:09:18 | |
Commentary by Dr. Valentin Fuster | |||
| Malignant Hypertension – A Systemic Cardiovascular Disease: JACC Review Topic of the Week | 22 Apr 2024 | 00:23:21 | |
Commentary by Dr. Valentin Fuster | |||
| JACC - April 16, 2024 Issue Summary | 08 Apr 2024 | 00:27:35 | |
Audio Summary of the April 16 issue of JACC, by Dr. Valentin Fuster | |||
| Variation in Health Status with Invasive vs Conservative Management of Chronic Coronary Disease | 08 Apr 2024 | 00:08:02 | |
Commentary by Dr. Valentin Fuster | |||
| Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score | 08 Apr 2024 | 00:10:40 | |
Commentary by Dr. Valentin Fuster | |||
| Water Conservation Overrides Osmotic Diuresis during SGLT2 Inhibition in Patients with Heart Failure | 08 Apr 2024 | 00:09:00 | |
Commentary by Dr. Valentin Fuster | |||
| Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults with Congenital Heart Disease | 08 Apr 2024 | 00:09:26 | |
Commentary by Dr. Valentin Fuster | |||
| 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction | 08 Apr 2024 | 00:03:50 | |
Commentary by Dr. Valentin Fuster | |||
| The Clinical Challenge of Prosthetic Valve Endocarditis: JACC Focus Seminar | 08 Apr 2024 | 00:09:06 | |
Commentary by Dr. Valentin Fuster | |||
| JACC - April 9, 2024 Issue Summary | 01 Apr 2024 | 00:27:23 | |
Audio Summary of the April 9 issue of JACC, by Dr. Valentin Fuster | |||
| Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials | 19 Aug 2024 | 00:10:16 | |
Dr. Valentin Fuster discusses a study on the efficacy of semaglutide for treating obesity-related heart failure with preserved ejection fraction, highlighting that the drug significantly reduced body weight and improved heart failure symptoms in both men and women. Notably, women experienced greater weight loss than men, but this did not translate into better improvement in heart failure-related symptoms, underscoring complex sex-related differences in cardiovascular health. | |||
| Transcatheter Myotomy to Reduce Left Ventricular Outflow Obstruction | 01 Apr 2024 | 00:10:03 | |
Commentary by Dr. Valentin Fuster | |||
| Stratifying Disease Progression in Patients with Cardiac ATTR Amyloidosis | 01 Apr 2024 | 00:10:16 | |
Commentary by Dr. Valentin Fuster | |||
| Efficacy and Safety of Dapagliflozin in Patients with Acute Heart Failure | 01 Apr 2024 | 00:12:48 | |
Commentary by Dr. Valentin Fuster | |||